Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Financial Results For Quarter And Financial Year Ended 31St March, 2021

 Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., June 29, 2021, inter alia, considered and approved: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and Financial year ended on March 31, 2021 along with Auditors report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. 2. Re-Appointment of M/s. Yash Mehta & Associates, Practicing Company Secretary, Ahmedabad as Secretarial Auditor of the Company for the F.Y. 2021-22. 3. Re-Appointment of M/s. MJV & Co, Chartered Accountants, Ahmedabad as an Internal Auditor of the Company for the F.Y. 2021-22. The Board Meeting of the Company commenced at 12:30 PM and concluded at 02:20 PM. This is for your information and records.
29-06-2021
Bigul

Medico Intercontinental Ltd - 539938 - Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.

 Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., June 29, 2021, inter alia, considered and approved: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and Financial year ended on March 31, 2021 along with Auditors report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. 2. Re-Appointment of M/s. Yash Mehta & Associates, Practicing Company Secretary, Ahmedabad as Secretarial Auditor of the Company for the F.Y. 2021-22. 3. Re-Appointment of M/s. MJV & Co, Chartered Accountants, Ahmedabad as an Internal Auditor of the Company for the F.Y. 2021-22. The Board Meeting of the Company commenced at 12:30 PM and concluded at 02:20 PM. This is for your information and records.
29-06-2021
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve Dear Sir/Ma'am, With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 29th June, 2021 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended 31st March, 2021 and any other business items as per agenda circulated. Further, in continuation of our earlier intimation dated March 31, 2021, in compliance of the provisions of the SEBI (Prohibition of Insider Trading) Regulations, the Trading window for dealing in the securities for all the designated persons including insiders has already been closed . You are requested to kindly take the same on your record.
22-06-2021
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Dear Sir/Madam, As per the provisions of 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), the compliances with corporate governance provisions as specified in Regulations 17 to 27 are applicable to the Company only if its paid up Capital exceeds Rs. 10 Crores and if Net worth is above Rs. 25 Crores. As on 31st March, 2021, the paid up share capital of the company is Rs. 3,24,90,000/- (Rupees Three Crores Twenty Four Lakhs Ninety Thousand only) which does not exceed Rs. 10 Crores limit and the Net Worth of the Company is Rs. 6,34,00,160/- (Rupees Six Crores Thirty Four Lakhs and One Hundred Sixty only) which does not cross Rs. 25 Crores. Hence, the compliance of provisions of Regulations 17 to 27 of SEBI (LODR) Regulations is not applicable to the Company. In light of the above, the Company is not required to file Annual Secretarial Compliance Report for the year ended 31st March, 2021. Kindly take the same on record.
22-06-2021
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir / Ma'am, We are enclosing herewith the Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March, 2021. Kindly take the above on your record.
12-04-2021
Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended March 31, 2021

 Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
10-04-2021
Bigul

Medico Intercontinental Ltd - 539938 - Submission Of Compliance Certificate Pursuant To Regulation 40(9) And 40(10) Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation, 2015 For The Period Of Half Year Ended 31St March, 2021.

 Dear Sir/Ma'am, We are herewith enclosing Compliance Certificate, pursuant to Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, issued by a Practicing Company Secretary for the period of half year ended 31st March, 2021. Kindly take the above on your records.
09-04-2021
Bigul

Medico Intercontinental Ltd - 539938 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayMedico Intercontinental Ltd 2CINL24100GJ1984PLC111413 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 5.40 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PUNEETA SHARMA Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: mail@medicointercontinental.com Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH Designation: CHIEF FINANCIAL OFFICER EmailId: mail@medicointercontinental.com Date: 07/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
07-04-2021
Bigul

Medico Intercontinental Ltd - 539938 - Compliance Certificate For The Period Ended 31St March, 2021.

 Sub.: Compliance under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on 31st March, 2021. Dear Sir/Madam, In terms of Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on 31st March, 2021, we hereby certify that all activities in relation to both physical and electronic share transfer facilities during the period 1st October, 2020 to 31st March, 2021 are maintained by company's registrar and share transfer agent Purva Sharegistry (India) Private Limited having registered office at 9, Shiv Shakti Industrial Estate, J.R. Boricha Marg, Opp Lower Parel (East), Mumbai - 400011 registered with Securities and Exchange Board of India bearing No. INR000001112.
05-04-2021
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Puneeta SharmaDesignation :- Company Secretary and Compliance Officer
05-04-2021
Next Page
Close

Let's Open Free Demat Account